TY - JOUR
T1 - Transient return of spontaneous circulation related to favourable outcomes in out-of-hospital cardiac arrest patients resuscitated with extracorporeal cardiopulmonary resuscitation
T2 - A secondary analysis of the SAVE-J II study
AU - SAVE-J II study group
AU - Otani, Takayuki
AU - Hifumi, Toru
AU - Inoue, Akihiko
AU - Abe, Toshikazu
AU - Sakamoto, Tetsuya
AU - Kuroda, Yasuhiro
AU - Sawano, Hirotaka
AU - Egawa, Yuko
AU - Sugiyama, Kazuhiro
AU - Tanabe, Maki
AU - Bunya, Naofumi
AU - Kasai, Takehiko
AU - Ijuin, Shinichi
AU - Nakayama, Shinichi
AU - Kanda, Jun
AU - Kanou, Seiya
AU - Takiguchi, Toru
AU - Yokobori, Shoji
AU - Takada, Hiroaki
AU - Inoue, Kazushige
AU - Takeuchi, Ichiro
AU - Honzawa, Hiroshi
AU - Kobayashi, Makoto
AU - Hamagami, Tomohiro
AU - Takayama, Wataru
AU - Otomo, Yasuhiro
AU - Maekawa, Kunihiko
AU - Shimizu, Takafumi
AU - Nara, Satoshi
AU - Nasu, Michitaka
AU - Takahashi, Kuniko
AU - Hagiwara, Yoshihiro
AU - Kushimoto, Shigeki
AU - Fukuda, Reo
AU - Ogura, Takayuki
AU - Shiraishi, Shin ichiro
AU - Zushi, Ryosuke
AU - Otani, Norio
AU - Kikuchi, Migaku
AU - Watanabe, Kazuhiro
AU - Nakagami, Takuo
AU - Shoko, Tomohisa
AU - Kitamura, Nobuya
AU - Matsuoka, Yoshinori
AU - Aoki, Makoto
AU - Sakuraya, Masaaki
AU - Arimoto, Hideki
AU - Homma, Koichiro
AU - Naito, Hiromichi
AU - Nakao, Shunichiro
N1 - Funding Information:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. We thank Editage for the English language editing. We also thank all the members of the SAVE-J II study group who participated in this study: Hirotaka Sawano, M.D. Ph.D. (Osaka Saiseikai Senri Hospital), Yuko Egawa, M.D. Shunichi Kato, M.D. (Saitama Red Cross Hospital), Kazuhiro Sugiyama, M.D. Maki Tanabe, M.D. (Tokyo Metropolitan Bokutoh Hospital), Naofumi Bunya, M.D. Takehiko Kasai, M.D. (Sapporo Medical University), Shinichi Ijuin, M.D. Shinichi Nakayama, M.D. Ph.D. (Hyogo Emergency Medical Center), Jun Kanda, M.D. Ph.D. Seiya Kanou, M.D. (Teikyo University Hospital), Toru Takiguchi, M.D. Shoji Yokobori, M.D. Ph.D. (Nippon Medical School), Hiroaki Takada, M.D. Kazushige Inoue, M.D. (National Hospital Organization Disaster Medical Center), Ichiro Takeuchi, M.D. Ph.D. Hiroshi Honzawa, M.D. (Yokohama City University Medical Center), Makoto Kobayashi, M.D. Ph.D. Tomohiro Hamagami, M.D. (Toyooka Public Hospital), Wataru Takayama, M.D. Yasuhiro Otomo, M.D. Ph.D. (Tokyo Medical and Dental University Hospital of Medicine), Kunihiko Maekawa, M.D. (Hokkaido University Hospital), Takafumi Shimizu, M.D. Satoshi Nara, M.D. (Teine Keijinkai Hospital), Michitaka Nasu, M.D. Kuniko Takahashi, M.D. (Urasoe General Hospital), Yoshihiro Hagiwara, M.D. M.P.H. (Imperial Foundation Saiseikai, Utsunomiya Hospital), Shigeki Kushimoto, M.D. Ph.D. (Tohoku University Graduate School of Medicine), Reo Fukuda, M.D. (Nippon Medical School Tama Nagayama Hospital), Takayuki Ogura, M.D. Ph.D. (Japan Red Cross Maebashi Hospital), Shin-ichiro Shiraishi, M.D. (Aizu Central Hospital), Ryosuke Zushi, M.D. (Osaka Mishima Emergency Critical Care Center), Norio Otani, M.D. (St. Luke's International Hospital), Migaku Kikuchi, M.D. Ph.D. (Dokkyo Medical University), Kazuhiro Watanabe, M.D. (Nihon University Hospital), Takuo Nakagami, M.D. (Omihachiman Community Medical Center), Tomohisa Shoko, M.D. Ph.D. (Tokyo Women's Medical University Medical Center East), Nobuya Kitamura, M.D. Ph.D. (Kimitsu Chuo Hospital), Takayuki Otani, M.D. (Hiroshima City Hiroshima Citizens Hospital), Yoshinori Matsuoka, M.D. Ph.D. (Kobe City Medical Center General Hospital), Makoto Aoki, M.D. Ph.D. (Gunma University Graduate School of Medicine), Masaaki Sakuraya, M.D. M.P.H. (JA Hiroshima General Hospital Hiroshima), Hideki Arimoto, M.D. (Osaka City General Hospital), Koichiro Homma, M.D. Ph.D. (Keio University School of Medicine), Hiromichi Naito, M.D. Ph.D. (Okayama University Hospital), Shunichiro Nakao, M.D. Ph.D. (Osaka University Graduate School of Medicine), Tomoya Okazaki, M.D. Ph.D. (Kagawa University Hospital), Yoshio Tahara, M.D. Ph.D. (National Cerebral and Cardiovascular Center), Hiroshi Okamoto, M.D, M.P.H. (St. Luke's International Hospital), Jun Kunikata, M.D. Ph.D. Hideto Yokoi, M.D. Ph.D. (Kagawa University Hospital).
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/12
Y1 - 2022/12
N2 - Aim: This study aimed to investigate the relationship between transient return of spontaneous circulation (ROSC) before extracorporeal membrane oxygenation (ECMO) initiation and outcomes in out-of-hospital cardiac arrest (OHCA) patients, who were resuscitated with extracorporeal cardiopulmonary resuscitation (ECPR). Methods: This study was a secondary analysis of the SAVE-J II study, which was a retrospective multicentre registry study involving 36 participating institutions in Japan. We classified patients into two groups according to the presence or absence of transient ROSC before ECMO initiation. Transient ROSC was defined as any palpable pulse of ≥1 min before ECMO initiation. The primary outcome was favourable neurological outcomes (cerebral performance categories 1–2). Results: Of 2,157 patients registered in the SAVE-J II study, 1,501 met the study inclusion criteria; 328 (22%) experienced transient ROSC before ECMO initiation. Patients with transient ROSC had better outcomes than those without ROSC (favourable neurological outcome, 26% vs 12%, P < 0.001; survival to hospital discharge, 46% vs 24%, respectively; P < 0.001). A Kaplan–Meier plot showed better survival in the transient ROSC group (log-rank test, P < 0.001). In multiple logistic analyses, transient ROSC was significantly associated with favourable neurological outcomes and survival (favourable neurological outcomes, adjusted odds ratio, 3.34 [95% confidence interval, 2.35–4.73]; survival, adjusted odds ratio, 3.99 [95% confidence interval, 2.95–5.40]). Conclusions: In OHCA patients resuscitated with ECPR, transient ROSC before ECMO initiation was associated with favourable outcomes. Hence, transient ROSC is a predictor of improved outcomes after ECPR.
AB - Aim: This study aimed to investigate the relationship between transient return of spontaneous circulation (ROSC) before extracorporeal membrane oxygenation (ECMO) initiation and outcomes in out-of-hospital cardiac arrest (OHCA) patients, who were resuscitated with extracorporeal cardiopulmonary resuscitation (ECPR). Methods: This study was a secondary analysis of the SAVE-J II study, which was a retrospective multicentre registry study involving 36 participating institutions in Japan. We classified patients into two groups according to the presence or absence of transient ROSC before ECMO initiation. Transient ROSC was defined as any palpable pulse of ≥1 min before ECMO initiation. The primary outcome was favourable neurological outcomes (cerebral performance categories 1–2). Results: Of 2,157 patients registered in the SAVE-J II study, 1,501 met the study inclusion criteria; 328 (22%) experienced transient ROSC before ECMO initiation. Patients with transient ROSC had better outcomes than those without ROSC (favourable neurological outcome, 26% vs 12%, P < 0.001; survival to hospital discharge, 46% vs 24%, respectively; P < 0.001). A Kaplan–Meier plot showed better survival in the transient ROSC group (log-rank test, P < 0.001). In multiple logistic analyses, transient ROSC was significantly associated with favourable neurological outcomes and survival (favourable neurological outcomes, adjusted odds ratio, 3.34 [95% confidence interval, 2.35–4.73]; survival, adjusted odds ratio, 3.99 [95% confidence interval, 2.95–5.40]). Conclusions: In OHCA patients resuscitated with ECPR, transient ROSC before ECMO initiation was associated with favourable outcomes. Hence, transient ROSC is a predictor of improved outcomes after ECPR.
KW - Extracorporeal cardiopulmonary resuscitation
KW - Out-of-hospital cardiac arrest
KW - Transient return of spontaneous circulation
UR - http://www.scopus.com/inward/record.url?scp=85138781597&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138781597&partnerID=8YFLogxK
U2 - 10.1016/j.resplu.2022.100300
DO - 10.1016/j.resplu.2022.100300
M3 - Article
AN - SCOPUS:85138781597
SN - 2666-5204
VL - 12
JO - Resuscitation Plus
JF - Resuscitation Plus
M1 - 100300
ER -